BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toden S, Tran HM, Tovar-Camargo OA, Okugawa Y, Goel A. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer. Oncotarget. 2016;7:16158-16171. [PMID: 26930714 DOI: 10.18632/oncotarget.7567] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 15.6] [Reference Citation Analysis]
Number Citing Articles
1 Kim D, Park M, Jang H, Hyun H, Lim W. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line. Lasers Med Sci 2018;33:57-66. [DOI: 10.1007/s10103-017-2335-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Ashry R, Elhussiny M, Abdellatif H, Elkashty O, Abdel-Ghaffar HA, Gaballa ET, Mousa SA. Genetic Interpretation of the Impacts of Honokiol and EGCG on Apoptotic and Self-Renewal Pathways in HEp-2 Human Laryngeal CD44high Cancer Stem Cells. Nutr Cancer 2021;:1-22. [PMID: 34590505 DOI: 10.1080/01635581.2021.1981404] [Reference Citation Analysis]
3 Shahabipour F, Caraglia M, Majeed M, Derosa G, Maffioli P, Sahebkar A. Naturally occurring anti-cancer agents targeting EZH2. Cancer Letters 2017;400:325-35. [DOI: 10.1016/j.canlet.2017.03.020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
4 Khan N, Mukhtar H. Tea Polyphenols in Promotion of Human Health. Nutrients 2018;11:E39. [PMID: 30585192 DOI: 10.3390/nu11010039] [Cited by in Crossref: 140] [Cited by in F6Publishing: 101] [Article Influence: 35.0] [Reference Citation Analysis]
5 Wang LX, Shi YL, Zhang LJ, Wang KR, Xiang LP, Cai ZY, Lu JL, Ye JH, Liang YR, Zheng XQ. Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer. Molecules. 2019;24:pii: E954. [PMID: 30857144 DOI: 10.3390/molecules24050954] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
6 Zhou Y, Xia L, Wang H, Oyang L, Su M, Liu Q, Lin J, Tan S, Tian Y, Liao Q, Cao D. Cancer stem cells in progression of colorectal cancer. Oncotarget. 2017;9:33403-33415. [PMID: 30279970 DOI: 10.18632/oncotarget.23607] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 14.6] [Reference Citation Analysis]
7 Arora I, Sharma M, Tollefsbol TO. Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy. Int J Mol Sci 2019;20:E4567. [PMID: 31540128 DOI: 10.3390/ijms20184567] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
8 Xing L, Zhang H, Qi R, Tsao R, Mine Y. Recent Advances in the Understanding of the Health Benefits and Molecular Mechanisms Associated with Green Tea Polyphenols. J Agric Food Chem 2019;67:1029-43. [PMID: 30653316 DOI: 10.1021/acs.jafc.8b06146] [Cited by in Crossref: 125] [Cited by in F6Publishing: 101] [Article Influence: 41.7] [Reference Citation Analysis]
9 Zhang W, Zhang W, Sun L, Xiang L, Lai X, Li Q, Sun S. The effects and mechanisms of epigallocatechin-3-gallate on reversing multidrug resistance in cancer. Trends in Food Science & Technology 2019;93:221-33. [DOI: 10.1016/j.tifs.2019.09.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
10 He SJ, Xiang CQ, Zhang Y, Lu XT, Chen HW, Xiong LX. Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition. Onco Targets Ther 2017;10:3435-51. [PMID: 28744148 DOI: 10.2147/OTT.S139546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
11 Liu C, Li P, Qu Z, Xiong W, Liu A, Zhang S. Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors. Molecules 2019;24:E1726. [PMID: 31058847 DOI: 10.3390/molecules24091726] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Gan R, Li H, Sui Z, Corke H. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Critical Reviews in Food Science and Nutrition 2017;58:924-41. [DOI: 10.1080/10408398.2016.1231168] [Reference Citation Analysis]
13 Jiang P, Xu C, Chen L, Chen A, Wu X, Zhou M, Haq IU, Mariyam Z, Feng Q. Epigallocatechin-3-gallate inhibited cancer stem cell-like properties by targeting hsa-mir-485-5p/RXRα in lung cancer. J Cell Biochem 2018;119:8623-35. [PMID: 30058740 DOI: 10.1002/jcb.27117] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
14 Adami GR, Tangney C, Schwartz JL, Dang KC. Gut/Oral Bacteria Variability May Explain the High Efficacy of Green Tea in Rodent Tumor Inhibition and Its Absence in Humans. Molecules 2020;25:E4753. [PMID: 33081212 DOI: 10.3390/molecules25204753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wang J, Wang W, Cai H, Du B, Zhang L, Ma W, Hu Y, Feng S, Miao G. MACC1 facilitates chemoresistance and cancer stem cell‑like properties of colon cancer cells through the PI3K/AKT signaling pathway. Mol Med Rep 2017;16:8747-54. [PMID: 28990068 DOI: 10.3892/mmr.2017.7721] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
16 Sethy C, Kundu CN. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother 2021;137:111285. [PMID: 33485118 DOI: 10.1016/j.biopha.2021.111285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
17 Eguchi H, Matsunaga T, Endo S, Ichihara K, Ikari A. Kaempferide Enhances Chemosensitivity of Human Lung Adenocarcinoma A549 Cells Mediated by the Decrease in Phosphorylation of Akt and Claudin-2 Expression. Nutrients 2020;12:E1190. [PMID: 32340376 DOI: 10.3390/nu12041190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Musial C, Kuban-Jankowska A, Gorska-Ponikowska M. Beneficial Properties of Green Tea Catechins. Int J Mol Sci 2020;21:E1744. [PMID: 32143309 DOI: 10.3390/ijms21051744] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 21.5] [Reference Citation Analysis]
19 Vittorio O, Curcio M, Cojoc M, Goya GF, Hampel S, Iemma F, Dubrovska A, Cirillo G. Polyphenols delivery by polymeric materials: challenges in cancer treatment. Drug Deliv 2017;24:162-80. [PMID: 28156178 DOI: 10.1080/10717544.2016.1236846] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
20 Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M. Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells. Mol Cells 2018;41:73-82. [PMID: 29429153 DOI: 10.14348/molcells.2018.2227] [Cited by in F6Publishing: 30] [Reference Citation Analysis]
21 Pandima Devi K, Rajavel T, Daglia M, Nabavi SF, Bishayee A, Nabavi SM. Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer. Semin Cancer Biol 2017;46:146-57. [PMID: 28185862 DOI: 10.1016/j.semcancer.2017.02.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
22 Buhrmann C, Yazdi M, Popper B, Shayan P, Goel A, Aggarwal BB, Shakibaei M. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells. Nutrients 2018;10:E888. [PMID: 30002278 DOI: 10.3390/nu10070888] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
23 Wang X, Wang X, Gu J, Zhou M, He Z, Wang X, Ferrone S. Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP. Oncotarget 2017;8:113837-46. [PMID: 29371950 DOI: 10.18632/oncotarget.22985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
24 Peng F, Xie X, Peng C. Chinese Herbal Medicine-Based Cancer Therapy: Novel Anticancer Agents Targeting MicroRNAs to Regulate Tumor Growth and Metastasis. Am J Chin Med 2019;47:1711-35. [PMID: 31801358 DOI: 10.1142/S0192415X19500873] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
25 Kim H, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J. Protective Effect of Green Tea Consumption on Colorectal Cancer Varies by Lifestyle Factors. Nutrients. 2019;11:pii: E2612. [PMID: 31683767 DOI: 10.3390/nu11112612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 de Melo FHM, Oliveira JS, Sartorelli VOB, Montor WR. Cancer Chemoprevention: Classic and Epigenetic Mechanisms Inhibiting Tumorigenesis. What Have We Learned So Far? Front Oncol 2018;8:644. [PMID: 30627525 DOI: 10.3389/fonc.2018.00644] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
27 Farooqi AA, Pinheiro M, Granja A, Farabegoli F, Reis S, Attar R, Sabitaliyevich UY, Xu B, Ahmad A. EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways. Cancers (Basel) 2020;12:E951. [PMID: 32290543 DOI: 10.3390/cancers12040951] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
28 Kang XL, He LR, Chen YL, Wang SB. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis. World J Gastroenterol 2020; 26(43): 6853-6866 [PMID: 33268966 DOI: 10.3748/wjg.v26.i43.6853] [Reference Citation Analysis]
29 Ndreshkjana B, Çapci A, Klein V, Chanvorachote P, Muenzner JK, Huebner K, Steinmann S, Erlenbach-Wuensch K, Geppert CI, Agaimy A, Ballout F, El-Baba C, Gali-Muhtasib H, Roehe AV, Hartmann A, Tsogoeva SB, Schneider-Stock R. Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells. Cell Death Dis 2019;10:379. [PMID: 31097715 DOI: 10.1038/s41419-019-1611-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
30 Zhao Y, Wang C, Goel A. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Carcinogenesis 2021;42:814-25. [PMID: 33822896 DOI: 10.1093/carcin/bgab027] [Reference Citation Analysis]
31 Shabbir U, Rubab M, Daliri EB, Chelliah R, Javed A, Oh DH. Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota. Nutrients 2021;13:206. [PMID: 33445760 DOI: 10.3390/nu13010206] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
32 Wan TM, Iyer DN, Ng L. Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer. Histol Histopathol 2020;35:225-37. [PMID: 31617575 DOI: 10.14670/HH-18-171] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
33 Han JH, Kim M, Kim HJ, Jang SB, Bae SJ, Lee IK, Ryu D, Ha KT. Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil. Int J Mol Sci 2021;22:5406. [PMID: 34065602 DOI: 10.3390/ijms22105406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Pons-Fuster López E, Gómez García F, López Jornet P. Combination of 5-Florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation. Arch Oral Biol 2019;101:8-12. [PMID: 30851692 DOI: 10.1016/j.archoralbio.2019.02.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
35 Parizadeh SM, Jafarzadeh-Esfehani R, Hassanian SM, Parizadeh SMR, Vojdani S, Ghandehari M, Ghazaghi A, Khazaei M, Shahidsales S, Rezayi M, Asgharzadeh F, Ghayour-Mobarhan M, Ferns GA, Avan A. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. Int J Biochem Cell Biol 2019;110:75-83. [PMID: 30818083 DOI: 10.1016/j.biocel.2019.02.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
36 Namiki K, Wongsirisin P, Yokoyama S, Sato M, Rawangkan A, Sakai R, Iida K, Suganuma M. (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells. Sci Rep 2020;10:2444. [PMID: 32051483 DOI: 10.1038/s41598-020-59281-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
37 Carotenuto F, Albertini MC, Coletti D, Vilmercati A, Campanella L, Darzynkiewicz Z, Teodori L. How Diet Intervention via Modulation of DNA Damage Response through MicroRNAs May Have an Effect on Cancer Prevention and Aging, an in Silico Study. Int J Mol Sci 2016;17:E752. [PMID: 27213347 DOI: 10.3390/ijms17050752] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
38 Lee J, Park M, Ko Y, Kim B, Kim O, Hyun H, Kim D, Sohn H, Moon YL, Lim W. Ectopic overexpression of CD133 in HNSCC makes it resistant to commonly used chemotherapeutics. Tumour Biol 2017;39:1010428317695534. [PMID: 28381190 DOI: 10.1177/1010428317695534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
39 Omer A, Barrera MC, Moran JL, Lian XJ, Di Marco S, Beausejour C, Gallouzi IE. G3BP1 controls the senescence-associated secretome and its impact on cancer progression. Nat Commun 2020;11:4979. [PMID: 33020468 DOI: 10.1038/s41467-020-18734-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
40 Hu Z, Li M, Cao Y, Akan OD, Guo T, Luo F. Targeting AMPK Signaling by Dietary Polyphenols in Cancer Prevention. Mol Nutr Food Res 2021;:e2100732. [PMID: 34802178 DOI: 10.1002/mnfr.202100732] [Reference Citation Analysis]
41 Sung TC, Huang WL, Ban LK, Lee HH, Wang JH, Su HY, Jen SH, Chang YH, Yang JM, Higuchi A, Ye Q. Enrichment of cancer-initiating cells from colon cancer cells through porous polymeric membranes by a membrane filtration method. J Mater Chem B 2020;8:10577-85. [PMID: 33124643 DOI: 10.1039/d0tb02312d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
42 Jiang P, Xu C, Chen L, Chen A, Wu X, Zhou M, Haq IU, Mariyam Z, Feng Q. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells. Molecular Carcinogenesis 2018;57:1835-44. [DOI: 10.1002/mc.22901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
43 Miyata Y, Matsuo T, Araki K, Nakamura Y, Sagara Y, Ohba K, Sakai H. Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer. Medicines (Basel) 2018;5:E87. [PMID: 30103466 DOI: 10.3390/medicines5030087] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
44 Negri A, Naponelli V, Rizzi F, Bettuzzi S. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer. Nutrients. 2018;10. [PMID: 30563268 DOI: 10.3390/nu10121936] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 20.5] [Reference Citation Analysis]
45 Pandiella-Alonso A, Díaz-Rodríguez E, Sanz E. Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review. Nutrients 2020;12:E2661. [PMID: 32878230 DOI: 10.3390/nu12092661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Chu M, Zheng C, Chen C, Song G, Hu X, Wang ZW. Targeting cancer stem cells by nutraceuticals for cancer therapy. Semin Cancer Biol 2021:S1044-579X(21)00202-9. [PMID: 34273521 DOI: 10.1016/j.semcancer.2021.07.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Sun C, Wang FJ, Zhang HG, Xu XZ, Jia RC, Yao L, Qiao PF. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway. World J Gastroenterol 2017; 23(10): 1816-1827 [PMID: 28348487 DOI: 10.3748/wjg.v23.i10.1816] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 59] [Article Influence: 11.2] [Reference Citation Analysis]
48 Granja A, Frias I, Neves AR, Pinheiro M, Reis S. Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems. Biomed Res Int 2017;2017:5813793. [PMID: 28791306 DOI: 10.1155/2017/5813793] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 12.2] [Reference Citation Analysis]
49 Jiang P, Chen A, Wu X, Zhou M, Ul Haq I, Mariyam Z, Feng Q. NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1. J Cell Physiol 2018;233:4852-63. [PMID: 29152741 DOI: 10.1002/jcp.26288] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
50 Gan L, Zhong L, Shan Z, Xiao C, Xu T, Song H, Li L, Yang R, Liu B. Epigallocatechin-3-gallate induces apoptosis in acute promyelocytic leukemia cells via a SHP-1-p38α MAPK-Bax cascade. Oncol Lett 2017;14:6314-20. [PMID: 29113283 DOI: 10.3892/ol.2017.6980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
51 Fujiki H, Sueoka E, Rawangkan A, Suganuma M. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. J Cancer Res Clin Oncol 2017;143:2401-12. [PMID: 28942499 DOI: 10.1007/s00432-017-2515-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
52 Zhou Y, Zheng J, Li Y, Xu DP, Li S, Chen YM, Li HB. Natural Polyphenols for Prevention and Treatment of Cancer. Nutrients 2016;8:E515. [PMID: 27556486 DOI: 10.3390/nu8080515] [Cited by in Crossref: 235] [Cited by in F6Publishing: 192] [Article Influence: 39.2] [Reference Citation Analysis]
53 Braicu C, Mehterov N, Vladimirov B, Sarafian V, Nabavi SM, Atanasov AG, Berindan-Neagoe I. Nutrigenomics in cancer: Revisiting the effects of natural compounds. Semin Cancer Biol 2017;46:84-106. [PMID: 28676460 DOI: 10.1016/j.semcancer.2017.06.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
54 Vincent A, Ouelkdite-Oumouchal A, Souidi M, Leclerc J, Neve B, Van Seuningen I. Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies. World J Stem Cells 2019; 11(11): 920-936 [PMID: 31768220 DOI: 10.4252/wjsc.v11.i11.920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
55 Khatoon E, Banik K, Harsha C, Sailo BL, Thakur KK, Khwairakpam AD, Vikkurthi R, Devi TB, Gupta SC, Kunnumakkara AB. Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.06.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
56 Li Y, Zhang T, Chen GY. Flavonoids and Colorectal Cancer Prevention. Antioxidants (Basel) 2018;7:E187. [PMID: 30544686 DOI: 10.3390/antiox7120187] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
57 Otsuka K, Ochiya T. Possible connection between diet and microRNA in cancer scenario. Seminars in Cancer Biology 2021;73:4-18. [DOI: 10.1016/j.semcancer.2020.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Nalli M, Puxeddu M, La Regina G, Gianni S, Silvestri R. Emerging Therapeutic Agents for Colorectal Cancer. Molecules 2021;26:7463. [DOI: 10.3390/molecules26247463] [Reference Citation Analysis]
59 Li Y, Gong P, Hou JX, Huang W, Ma XP, Wang YL, Li J, Cui XB, Li N. miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells. J Immunol Res 2018;2018:7498514. [PMID: 30175154 DOI: 10.1155/2018/7498514] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
60 Toden S, Ravindranathan P, Gu J, Cardenas J, Yuchang M, Goel A. Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer. Sci Rep. 2018;8:3335. [PMID: 29463813 DOI: 10.1038/s41598-018-21478-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
61 Wang R, Huang J, Chen J, Yang M, Wang H, Qiao H, Chen Z, Hu L, Di L, Li J. Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles. Nanomedicine 2019;21:102068. [PMID: 31374249 DOI: 10.1016/j.nano.2019.102068] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
62 Liu L, Ju Y, Wang J, Zhou R. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells. Pathol Res Pract 2017;213:1242-50. [PMID: 28964574 DOI: 10.1016/j.prp.2017.09.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
63 Deldar Abad Paskeh M, Asadi S, Zabolian A, Saleki H, Khoshbakht MA, Sabet S, Naghdi MJ, Hashemi M, Hushmandi K, Ashrafizadeh M, Mirzaei S, Zarrabi A, Sethi G. Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies. Int J Mol Sci 2021;22:11669. [PMID: 34769099 DOI: 10.3390/ijms222111669] [Reference Citation Analysis]
64 Li F, Qasim S, Li D, Dou QP. Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator. Semin Cancer Biol 2021:S1044-579X(20)30256-X. [PMID: 33453404 DOI: 10.1016/j.semcancer.2020.11.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 He F, Chen H, Yang P, Wu Q, Zhang T, Wang C, Wei J, Chen Z, Hu H, Li W, Cao J. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression. Oncotarget 2016;7:81156-71. [PMID: 27835604 DOI: 10.18632/oncotarget.13215] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
66 Chen Y, Wang XQ, Zhang Q, Zhu JY, Li Y, Xie CF, Li XT, Wu JS, Geng SS, Zhong CY, Han HY. (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway. Nutrients 2017;9:E572. [PMID: 28587207 DOI: 10.3390/nu9060572] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 10.4] [Reference Citation Analysis]
67 De Robertis M, Poeta ML, Signori E, Fazio VM. Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells. Semin Cancer Biol 2018;53:232-47. [PMID: 30130662 DOI: 10.1016/j.semcancer.2018.08.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
68 Albuquerque C, Pebre Pereira L. Wnt Signalling-Targeted Therapy in the CMS2 Tumour Subtype: A New Paradigm in CRC Treatment? Adv Exp Med Biol 2018;1110:75-100. [PMID: 30623367 DOI: 10.1007/978-3-030-02771-1_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
69 Rady I, Mohamed H, Rady M, Siddiqui IA, Mukhtar H. Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea. Egyptian Journal of Basic and Applied Sciences 2019;5:1-23. [DOI: 10.1016/j.ejbas.2017.12.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 11.3] [Reference Citation Analysis]
70 Moracci L, Crotti S, Traldi P, Agostini M. Mass spectrometry in the study of molecular complexes between 5-fluorouracil and catechins. J Mass Spectrom 2021;56:e4682. [PMID: 33448570 DOI: 10.1002/jms.4682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Silva VR, Santos LS, Dias RB, Quadros CA, Bezerra DP. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells. Cancer Commun (Lond) 2021. [PMID: 34791817 DOI: 10.1002/cac2.12235] [Reference Citation Analysis]
72 Huang D, Cui L, Ahmed S, Zainab F, Wu Q, Wang X, Yuan Z. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs. Food and Chemical Toxicology 2019;123:574-94. [DOI: 10.1016/j.fct.2018.10.052] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
73 Wang X, Liu C, Wang J, Fan Y, Wang Z, Wang Y. Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer. Oncotarget 2017;8:58801-8. [PMID: 28938598 DOI: 10.18632/oncotarget.18522] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
74 Shigeyasu K, Okugawa Y, Toden S, Miyoshi J, Toiyama Y, Nagasaka T, Takahashi N, Kusunoki M, Takayama T, Yamada Y, Fujiwara T, Chen L, Goel A. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer. JCI Insight 2018;3:99976. [PMID: 29925690 DOI: 10.1172/jci.insight.99976] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
75 Akar RO, Selvi S, Ulukaya E, Aztopal N. Key actors in cancer therapy: epigenetic modifiers. Turk J Biol 2019;43:155-70. [PMID: 31320814 DOI: 10.3906/biy-1903-39] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Montgomery M, Srinivasan A. Epigenetic Gene Regulation by Dietary Compounds in Cancer Prevention. Adv Nutr 2019;10:1012-28. [PMID: 31100104 DOI: 10.1093/advances/nmz046] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
77 Atanasov AG, Sabharanjak SM, Zengin G, Mollica A, Szostak A, Simirgiotis M, Huminiecki Ł, Horbanczuk OK, Nabavi SM, Mocan A. Pecan nuts: A review of reported bioactivities and health effects. Trends in Food Science & Technology 2018;71:246-57. [DOI: 10.1016/j.tifs.2017.10.019] [Cited by in Crossref: 53] [Cited by in F6Publishing: 15] [Article Influence: 13.3] [Reference Citation Analysis]
78 Gan RY, Li HB, Sui ZQ, Corke H. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Crit Rev Food Sci Nutr 2018;58:924-41. [PMID: 27645804 DOI: 10.1080/10408398.2016.1231168] [Cited by in Crossref: 129] [Cited by in F6Publishing: 116] [Article Influence: 25.8] [Reference Citation Analysis]
79 Shah D, Gandhi M, Kumar A, Cruz-Martins N, Sharma R, Nair S. Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention. Crit Rev Food Sci Nutr 2021;:1-37. [PMID: 34433338 DOI: 10.1080/10408398.2021.1968786] [Reference Citation Analysis]